Also trades as: FBIO (NASDAQ) · $vol 1M
FBIOP NASDAQ
Fortress Biotech, Inc.
1W: +1.4%
1M: -9.8%
3M: -16.6%
YTD: +66.1%
1Y: +124.5%
3Y: +46.7%
5Y: -12.3%
$16.86
+0.80 (+4.98%)
Weekly Expected Move ±3.6%
$16
$16
$17
$17
$18
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Revenue Segmentation
By Product / Service
Revenue by Segment (5-Year Trend)
Income Trends
Revenue
$58M
-31.8% ▼
5Y CAGR: +9.5%
Gross Profit
$37M
-40.3% ▼
5Y CAGR: +7.1%
Operating Income
-$110M
+22.5% ▲
Net Income
-$46M
+24.1% ▲
EPS (Diluted)
$-2.69
+68.2% ▲
EBITDA
-$104M
+23.0% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $46M | $69M | $76M | $85M | $58M |
| YoY Growth | +24.5% | +50.9% | +10.1% | +11.6% | -31.8% |
| Cost of Revenue | $15M | $32M | $31M | $23M | $21M |
| Gross Profit | $31M | $37M | $45M | $62M | $37M |
| Gross Margin | 68.0% | 53.4% | 59.4% | 72.9% | 63.8% |
| R&D Expenses | $64M | $129M | $135M | $106M | $57M |
| SG&A Expenses | $61M | $87M | $114M | $91M | $88M |
| Operating Expenses | $125M | $225M | $249M | $204M | $147M |
| Operating Income | -$94M | -$189M | -$204M | -$142M | -$110M |
| Operating Margin | -206.7% | -274.1% | -268.8% | -168.4% | -191.4% |
| Interest Expense | $15M | $15M | $14M | $13M | $10M |
| Income Before Tax | -$103M | -$164M | -$213M | -$154M | -$121M |
| Tax Expense | $136K | $473K | $449K | $521K | $312K |
| Net Income | -$47M | -$65M | -$87M | -$61M | -$46M |
| Net Margin | -102.0% | -94.1% | -114.3% | -71.7% | -79.8% |
| EPS (Diluted) | $-9.75 | $-11.85 | $-14.55 | $-8.47 | $-2.69 |
| EBITDA | -$88M | -$146M | -$194M | -$136M | -$104M |
| Shares Outstanding | 5M | 5M | 6M | 8M | 21M |